Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2078 | 4804 | 34.3 | 68% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
103 | 71673 | DOPAMINE//PSYCHOPHARMACOLOGY//NUCLEUS ACCUMBENS |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
2356 | 2203 | C 11RACLOPRIDE//C 11FLB 457//F 18 FALLYPRIDE |
11380 | 919 | WATER TARGET//CIDG//O 18H2O |
13830 | 747 | CARBON 11//C 11CARBON MONOXIDE//C 11METHYL IODIDE |
13888 | 743 | FLUORINE 18//F 18SFB//RADIOFLUORINATION |
31996 | 115 | N 13NH3//NITROGEN 13//MED CHEM NEUROENGN |
34143 | 77 | ACID INDUCED INDOLE CYCLIZATION//22810 TAMAGAWA SETAGAYA KU//DECARBOXYLATIVE CYCLIZATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | C 11RACLOPRIDE | Author keyword | 75 | 68% | 1% | 66 |
2 | FLUORINE 18 | Author keyword | 53 | 27% | 4% | 169 |
3 | C 11FLB 457 | Author keyword | 52 | 87% | 1% | 26 |
4 | F 18 FALLYPRIDE | Author keyword | 38 | 93% | 0% | 14 |
5 | CARBON 11 | Author keyword | 33 | 25% | 2% | 113 |
6 | F 18FALLYPRIDE | Author keyword | 32 | 85% | 0% | 17 |
7 | EPIDEPRIDE | Author keyword | 27 | 78% | 0% | 18 |
8 | RACLOPRIDE | Author keyword | 26 | 24% | 2% | 98 |
9 | C 11MNPA | Author keyword | 26 | 100% | 0% | 11 |
10 | C 11 RACLOPRIDE | Author keyword | 26 | 63% | 1% | 26 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | C 11RACLOPRIDE | 75 | 68% | 1% | 66 | Search C+11RACLOPRIDE | Search C+11RACLOPRIDE |
2 | FLUORINE 18 | 53 | 27% | 4% | 169 | Search FLUORINE+18 | Search FLUORINE+18 |
3 | C 11FLB 457 | 52 | 87% | 1% | 26 | Search C+11FLB+457 | Search C+11FLB+457 |
4 | F 18 FALLYPRIDE | 38 | 93% | 0% | 14 | Search F+18+FALLYPRIDE | Search F+18+FALLYPRIDE |
5 | CARBON 11 | 33 | 25% | 2% | 113 | Search CARBON+11 | Search CARBON+11 |
6 | F 18FALLYPRIDE | 32 | 85% | 0% | 17 | Search F+18FALLYPRIDE | Search F+18FALLYPRIDE |
7 | EPIDEPRIDE | 27 | 78% | 0% | 18 | Search EPIDEPRIDE | Search EPIDEPRIDE |
8 | RACLOPRIDE | 26 | 24% | 2% | 98 | Search RACLOPRIDE | Search RACLOPRIDE |
9 | C 11MNPA | 26 | 100% | 0% | 11 | Search C+11MNPA | Search C+11MNPA |
10 | C 11 RACLOPRIDE | 26 | 63% | 1% | 26 | Search C+11+RACLOPRIDE | Search C+11+RACLOPRIDE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | C 11 RACLOPRIDE | 133 | 46% | 4% | 215 |
2 | C 11 RACLOPRIDE BINDING | 125 | 74% | 2% | 93 |
3 | LIVING HUMAN BRAIN | 115 | 44% | 4% | 197 |
4 | H 3 RACLOPRIDE | 93 | 63% | 2% | 95 |
5 | F 18 | 78 | 32% | 4% | 203 |
6 | ENDOGENOUS DOPAMINE | 75 | 34% | 4% | 181 |
7 | DOUBLE BLIND PET | 57 | 59% | 1% | 65 |
8 | I 125 EPIDEPRIDE | 54 | 71% | 1% | 44 |
9 | HIGH AFFINITY STATE | 53 | 64% | 1% | 52 |
10 | F 18 FALLYPRIDE | 48 | 76% | 1% | 34 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Consensus nomenclature for in vivo imaging of reversibly binding radioligands | 2007 | 537 | 11 | 91% |
The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment | 2012 | 123 | 100 | 78% |
Synthesis of C-11, F-18, O-15, and N-13 Radiolabels for Positron Emission Tomography | 2008 | 304 | 282 | 57% |
The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway | 2009 | 563 | 142 | 34% |
The dopamine theory of addiction: 40 years of highs and lows | 2015 | 4 | 121 | 49% |
Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Routes | 2015 | 4 | 129 | 45% |
Chemistry with [F-18]fluoride ion | 2008 | 218 | 137 | 57% |
Molecular imaging with PET | 2008 | 332 | 129 | 37% |
Atypical antipsychotics: Mechanism of action | 2002 | 403 | 50 | 58% |
Antipsychotic Occupancy of Dopamine Receptors in Schizophrenia | 2011 | 51 | 85 | 67% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VIVIAN RAKOFF POSITRON EMISS TOMOG UNIT | 11 | 100% | 0.1% | 6 |
2 | PSYCHIAT IMAGING GRP | 9 | 64% | 0.2% | 9 |
3 | MOL NEUROIMAGING GRP | 6 | 35% | 0.3% | 14 |
4 | MOL IMAGING BRANCH | 6 | 13% | 0.9% | 41 |
5 | PET CHEM GRP | 6 | 100% | 0.1% | 4 |
6 | CLIN NEUROIMAGING TEAM | 5 | 60% | 0.1% | 6 |
7 | IZOPHRENIA CONTINUING CARE | 4 | 67% | 0.1% | 4 |
8 | INDIANA UNIV NEUROIMAGING | 4 | 75% | 0.1% | 3 |
9 | IZOPHRENIA COGNIT DISORDER DISCOVERY PERFORM | 4 | 75% | 0.1% | 3 |
10 | SECT NEUROCHEM IMAGING | 4 | 50% | 0.1% | 6 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000016510 | DIMEBON//DIMEBOLIN//REMOXIPRIDE |
2 | 0.0000015875 | IEEE TRANSACTIONS ON NUCLEAR SCIENCE//PHYSICS IN MEDICINE AND BIOLOGY//DEPTH OF INTERACTION |
3 | 0.0000014133 | ALPHAVBETA3 INTEGRIN//CILENGITIDE//DISCOIDIN DOMAIN RECEPTOR |
4 | 0.0000013708 | PERIPHERAL BENZODIAZEPINE RECEPTORS//TSPO//DIAZEPAM BINDING INHIBITOR |
5 | 0.0000011896 | RISPERIDONE//CLOZAPINE//OLANZAPINE |
6 | 0.0000011554 | NUCLEUS ACCUMBENS//COCAINE//DOPAMINE |
7 | 0.0000011378 | SEROTONIN//5 HT1A RECEPTOR//5 HT1A RECEPTORS |
8 | 0.0000011332 | NUCL MED//PET CT//SCINTIMAMMOGRAPHY |
9 | 0.0000010834 | PARKINSONS DISEASE//DEEP BRAIN STIMULATION//MOVEMENT DISORDERS |
10 | 0.0000009451 | EXCITATION FUNCTIONS//INTEGRAL YIELD//RADIATION SYNOVECTOMY |